Cochrane2022IaEN
Cochrane Review: Ultrafiltration for acute heart failure
Zusammenfassung
# Ultrafiltration for acute heart failure.
## BACKGROUND
Pharmacotherapies such as loop diuretics are the cornerstone treatment for acute heart failure (AHF), but resistance and poor response can occur. Ultrafiltration (UF) is an alternative therapy to reduce congestion, however its benefits, efficacy and safety are unclear.
## OBJECTIVES
To assess the effects of UF compared to diuretic therapy on clinical outcomes such as mortality and rehospitalisation rates.
## SEARCH METHODS
We underto
Kerninformationen
tics in adults with AHF.
## DATA COLLECTION AND ANALYSIS
Two review authors independently assessed trial quality and extracted data. We contacted study authors for any further information, and language interpreters to translate texts. We assessed risk of bias in included studies using Risk of Bias...
tic use during UF. There was high risk of bias in some studies, particularly with deviations from the intended protocols from high cross-overs as well as missing outcome data for long-term follow-up. We are uncertain about the effect of UF on all-cause mortality at 30 days or less (risk ratio (RR) ...
at longest available follow-up (RR 0.91, 95% CI 0.79 to 1.05; 6 studies, 612 participants; low-certainty evidence). UF may reduce heart failure-related rehospitalisation at 30 days or less (RR 0.62, 95% CI 0.37 to 1.04; 2 studies, 395 participants; low-certainty evidence). UF probably reduces heart ...
Fragen zu diesem Thema?
ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.
Jetzt auf ClariMed suchenVerwandte Leitlinien
Cochrane2024
Cochrane Review: Continuous infusion versus bolus injection of loop diuretics for acute heart failure
Cochrane2020
Cochrane Review: Pharmacological interventions for heart failure in people with chronic kidney disease
Cochrane2020
Cochrane Review: Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy
Cochrane2021
Cochrane Review: Non-pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy
Cochrane2021
Cochrane Review: Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction
Cochrane2024
Cochrane Review: Anticoagulation for people receiving long-term haemodialysis
Cochrane2019
Cochrane Review: Disease management interventions for heart failure
KDIGO2026